Diagnosis Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter Two-way Non-intervention Study

  • STATUS
    Recruiting
  • participants needed
    5000
  • sponsor
    Beijing Tsinghua Chang Gung Hospital
Send
Updated on 19 February 2024
See if I qualify
cancer
cholangiocarcinoma

Summary

This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival

Secondary purpose:

  1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer
  2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer

Details
Condition Adenocarcinoma, Adenocarcinoma, Cholangiocarcinoma
Age 18years - 100years
Clinical Study IdentifierNCT04243057
SponsorBeijing Tsinghua Chang Gung Hospital
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

above the age of 18 years old, male or female
clinical diagnosis of patients with cholangiocarcinoma
Child-Pugh classification of A, B
Eastern Cooperative Oncology Group scoring system (ECOG) score of 0-2 points

Exclusion Criteria

None
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer
cholangiocarcinoma

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.